2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo
- 1 April 1994
- journal article
- Published by Elsevier in Neuroscience
- Vol. 59 (4) , 931-938
- https://doi.org/10.1016/0306-4522(94)90296-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Localization of AMPA receptor subunits in rat CNS using anti-peptide antibodiesNeuroReport, 1993
- The AMPA antagonist, NBQX, protects against ischemia-induced loss of cerebellar Purkinje cellsNeuroReport, 1992
- Protection against ischemic hippocampal CAI damage in the rat with a new non-NMDA antagonist, NBQXActa Neurologica Scandinavica, 1992
- Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPANature, 1991
- Molecular Cloning and Functional Expression of Glutamate Receptor Subunit GenesScience, 1990
- A Family of AMPA-Selective Glutamate ReceptorsScience, 1990
- Sequence and expression of a frog brain complementary DNA encoding a kainate-binding proteinNature, 1989
- In Vivo Brain Dialysis of Amino Acids and Simultaneous EEG Measurements Following Intrahippocampal Quinolinic Acid Injection: Evidence for a Dissociation Between Neurochemical Changes and SeizuresJournal of Neurochemistry, 1985
- Lesion of striatal neurons with kainic acid provides a model for Huntington's choreaNature, 1976
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975